Noncoding RNAs in Health and Disease

Noncoding RNAs in Health and Disease – Keystone Symposia – February 21—24, 2016 – Santa Fe Community Convention Center, Santa Fe, New Mexico, USA

Noncoding RNAs in Health and Disease - Keystone Symposia

Over the past decade, there has been a greater understanding of genomic complexity in eukaryotes ushered in by the immense technological advances in high-throughput sequencing of DNA and its corresponding RNA transcripts. This has resulted in the realization that beyond protein-coding genes, there are a large number of transcripts that do not encode for proteins and, therefore, may perform their function through RNA sequences and/or through secondary and tertiary structural determinants. This Keystone Symposia meeting is focused on the latest findings concerning different classes of noncoding RNAs that use different strategies to regulate transcription. These are exciting times for discovering the biological scope and the mechanism of action for these RNA molecules, which have roles in dosage compensation, imprinting, enhancer function and transcriptional regulation, with a consequently great impact in development and disease.

More about Noncoding RNAs in Health and Disease – Keystone Symposia : http://www.keystonesymposia.org/16Q5

Noncoding RNAs in Health and Disease – Keystone Symposia – February 21—24, 2016 – Santa Fe Community Convention Center, Santa Fe, New Mexico, USA

Noncoding RNAs in Health and Disease – Keystone Symposia – February 21—24, 2016 – Santa Fe Community Convention Center, Santa Fe, New Mexico, USA